Literature DB >> 26370605

Breast cancer: Tracking ctDNA to evaluate relapse risk.

Diana Romero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26370605     DOI： 10.1038/nrclinonc.2015.159

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  3 in total

1.  Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.

Authors:  Ligang Xia; Zhoufang Li; Bo Zhou; Geng Tian; Lidong Zeng; Hongyu Dai; Xiaohua Li; Chaoyu Liu; Shixin Lu; Feiyue Xu; Xiaonian Tu; Fang Deng; Yuancai Xie; Weiren Huang; Jiankui He
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

2.  Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.

Authors:  Zhe-Yu Hu; Ning Xie; Can Tian; Xiaohong Yang; Liping Liu; Jing Li; Huawu Xiao; Hui Wu; Jun Lu; Jianxiang Gao; Xuming Hu; Min Cao; Zhengrong Shui; Mengjia Xiao; Yu Tang; Qiongzhi He; Lianpeng Chang; Xuefeng Xia; Xin Yi; Qianjin Liao; Quchang Ouyang
Journal:  EBioMedicine       Date:  2018-05-26       Impact factor: 8.143

Review 3.  Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.

Authors:  Feifei Cheng; Li Su; Cheng Qian
Journal:  Oncotarget       Date:  2016-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.